Skip to content

Wesley C Ryan

Wesley Ryan, MD, and Associates, Los Angeles, CA, USA.

3 papers in the library · 38 citations · publishing 2015-2024

Papers

Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS.

Scientific reports July 19, 2023 Adelaida Castillo, Julien Dubois, Ryan M Field et al. 19 citations

Ketamine administration in healthy participants caused an altered state of consciousness and changes in systemic physiology, including increased pulse rate and electrodermal activity. The drug led to a brain-wide reduction in the fractional amplitude of low frequency fluctuations and decreased global brain connectivity in the prefrontal region. Preliminary evidence suggests that a combination of neural and physiological metrics may predict subjective mystical experiences and reductions in depressive symptoms. The study demonstrates the successful use of fNIRS neuroimaging to measure physiological effects of ketamine in a clinical setting, representing a step toward larger clinical fNIRS studies of psychedelics.

Mania following use of ibogaine: A case series.

The American journal on addictions April 1, 2015 Cole J Marta, Wesley C Ryan, Alex Kopelowicz et al. 17 citations

Ibogaine, a naturally occurring hallucinogen used illegally for addiction treatment, can trigger manic episodes even in people with no prior bipolar diagnosis. This case series reports three patients who developed mania after using unregulated ibogaine—two for self-treating addictions and one for psycho-spiritual purposes. No previous reports of ibogaine-induced mania exist in the literature. Clinicians encountering new-onset mania should inquire about substance use, especially ibogaine, given its growing popularity among vulnerable populations seeking addiction treatment. The authors advise discussing the lack of safety and efficacy data with patients considering ibogaine.

Maintenance Intramuscular Ketamine-Assisted Psychotherapy, a Retrospective Chart Review of Efficacy, Adverse Events, and Dropouts from a Community Practice.

Journal of psychoactive drugs November 22, 2024 Wesley C Ryan, Boris D Heifets 2 citations

In an addiction psychiatry practice offering intramuscular ketamine with psychotherapy for depression, 70 patients received 1,114 sessions over nearly seven years. Induction produced an 82% response, and improvement remained above 80% after six months of maintenance sessions given every 21 days at a mean dose of 1.13 mg/kg. Many patients (38%) stayed in treatment for at least a year. Dropouts were mostly due to logistical reasons (50%); side effects accounted for only 9.7%. One case of ketamine use disorder required residential treatment. Nausea was the main side effect managed with medication. Maintenance ketamine-assisted psychotherapy extended benefits for mood, anxiety, and substance use and was generally well tolerated.